PerkinElmer

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment consists of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.

Is (PKI) Outperforming Other Computer and Technology Stocks This Year?

Has PerkinElmer (PKI) Outpaced Other Computer and Technology Stocks This Year?

Oxford Immunotec Global

Oxford Immunotec Global shares surged Thursday after PerkinElmer agreed to buy the diagnostics-focused medical stock for $591 million. This follows its plan to buy Horizon Discovery.

Medical Stock Mashup: PerkinElmer, Oxford Unite In $591 Million Deal

WALTHAM, Mass. & LONDON--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Oxford Immunotec Global PLC (NASDAQ: OXFD) ("Oxford Immunotec" or the “Company”) are pleased to announce they have reached an agreement on terms under which PerkinElmer will acquire Oxford Immunotec (the “Acquisition”). It is intended that the Acquisition will be implemented by means of a U.K. High Court of Justice-sanctioned scheme of arrangement under Part 26 of the U.K. Companies Act 2006 between Oxfo

PerkinElmer to Acquire Oxford Immunotec Global PLC

PerkinElmer's shares have risen more than 47% in 2020, so why isn't everyone talking about this fast-rising testing company?

Why Is Nobody Talking About PerkinElmer Stock?

General Motors

Hologic

Owens & Minor

Top Ranked Growth Stocks to Buy for December 11th

Does PerkinElmer (PKI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Here's Why Momentum Investors Will Love PerkinElmer (PKI)

Avnet

Federated Hermes

Top Ranked Growth Stocks to Buy for December 8th

PerkinElmer (PKI) possesses solid growth attributes, which could help it handily outperform the market.

Is PerkinElmer (PKI) a Solid Growth Stock? 3 Reasons to Think " Yes "

Deere & Company

IPG Photonics

Landbridge Co LLC

Qorvo

It will be prudent to invest in Zacks top-Ranked S&P 500 stocks that have skyrocketed year to date with strong potential for 2021. These include DE, HOLX, LB, PKI, IPGP, QRVO.

6 S&P 500 Must-Buy Stocks for 2021 Flying High Amid Pandemic

Generac Holdings

Boston Beer Company

Ubiquiti Inc

We have narrowed our search to five mid-cap stocks that have become large caps during the coronavirus hit past eight and a half months. These are: SAM, LB, PKI, UI, GNRC.

5 Mid-Cap Stocks That Became Top Large Caps Amid Pandemic

Labcorp Holdings Inc

Thermo Fisher Scientific

Here are a few coronavirus-testing MedTech stocks that investors can scoop up to reap profits amid the pandemic-battered stock market situation.

4 MedTech Stocks Gaining Ground on COVID-19 Test Kit Success

Is PerkinElmer (PKI) Stock Outpacing Its Computer and Technology Peers This Year?

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., announced today the Lighthouse Lab in Charnwood, Loughborough, England is now processing COVID-19 testing samples as part of the Company's collaboration with the Department of Health and Social Care (DHSC) in support of the UK Government's NHS Test and Trace program. The facility, operated by PerkinElmer Genomics, began processing samples today, and with its team of 400 scientists, researchers, technicians and operations personnel, has the cap

Charnwood Lighthouse Lab Goes Live Processing Thousands of COVID-19 Tests per Day with PerkinElmer Solutions

PerkinElmer has been a huge beneficiary of Covid-19 thanks to its diagnostics business. Shares have done well this year, but momentum has been reasonable.

PerkinElmer - Passing The Test

3 Reasons Why Growth Investors Shouldn't Overlook PerkinElmer (PKI)

Best Buy

America's Car-Mart

IDEXX Laboratories

Americas CarMart (CRMT), Best Buy (BBY), IDEXX Laboratories (IDXX) and PerkinElmer (PKI) currently flaunt striking earnings growth and positive estimate revisions.

4 of the Best Stocks That Boast Solid Earnings Growth

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. announced today that its PerkinElmer® SARS-CoV-2 Real-time RT-PCR Assay received CE-IVD marking for the use of saliva as specimen type and the option to pool up to five specimens collected from individuals suspected of COVID-19 or asymptomatic individuals. SARS-CoV-2 testing using saliva is less invasive, reduces the risk of exposure to healthcare workers involved in sample collection and need for frequent replacement of personal protective equ

PerkinElmer SARS-CoV-2 RT-PCR Assay Receives CE Mark for Saliva and Sample Pooling to Test Symptomatic and Asymptomatic Individuals

As of late, it has definitely been a great time to be an investor in PerkinElmer (PKI).

PerkinElmer's (PKI) Shares March Higher, Can It Continue?

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will host a Virtual Life Science Event for the investment community on Thursday, December 10 at 8:30 a.m. ET. This event is organized to serve as an in-depth breakdown of the Company's business serving Life Science End Markets, including its portfolio, strategy, latest innovations and scientific advances. Speakers will include Jamey Mock

PerkinElmer to Host Virtual Life Science Event

PerkinElmer's (PKI) new saliva-based collection and asymptomatic test solution receives CE-IVD mark.

PerkinElmer's Non-Invasive Saliva-Based Testing Gets CE Mark

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer introduces new LC solution bringing together advanced HPLC and UHPLC capabilities with intuitive instrument control and data analysis.

PerkinElmer Launches New HPLC, UHPLC and Next Generation Software Solution

Is PerkinElmer (PKI) Outperforming Other Computer and Technology Stocks This Year?

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. today launched its newest ChemDraw® application, ChemOffice®+ Cloud, to accelerate chemistry communication workflows.

PerkinElmer Brings ChemDraw Software to the Cloud, Enhancing Search and Collaboration Workflows

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that EUROIMMUN, a PerkinElmer company, has launched the Anti-SARS-CoV-2 QuantiVacTM ELISA (IgG) to quantify IgG antibodies against the SARS-CoV-2 S1 antigen. The assay is available for countries accepting the CE mark, and the Company plans to file a request for this product with the U.S. Food and Drug Administration for Emergency Use Authorization (EUA).

EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 Protein

Aaron's

Newmont Mining

Teradyne

Tapestry

Sales growth is a major indicator of a company's health and ability to sustain business. Let's check out - Tapestry (TPR), Newmont (NEM), Teradyne (TER), Aarons (AAN) & PerkinElmer (PKI) - as these are likely to see solid sales growth.

News for PerkinElmer Stock (PKI)